SBRT for Non-Small Cell Carcinoma

Using the TomoTherapy® Hi·Art® system’s precise dose guidance capabilities, the oncologist delivered intense radiation directly to the tumor during a week and a half of treatment. The patient experienced no side effects during this time and continued to work as a nurse. Three years later, she remains disease free.

 

This section provides CyberKnife and TomoTherapy case studies, created by Accuray in collaboration with our centers, showcasing positive outcomes. Individual treatment results may vary. Please consult a physician to discuss individual cases, including eligibility for treatment with Accuray devices.

This section also provides a selected list of publications supporting the use and efficacy of the CyberKnife and TomoTherapy Systems and is not inclusive of all available publications.

For access to a more comprehensive listing of publications related to CyberKnife and TomoTherapy Systems, visit www.pubmed.com.